Hi Red bar, Yes I agree the OSA data was awesome. Did you...

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #

First 20 Last

Share
Profile

Follow
Myeverywish

3,464 Posts.

956

15/03/20

11:38

Post #: 43500190
Share

Originally posted by Red bar ↑

LOL friends with benefits too funny mate! I agree!

Said to TK on the phone a couple of days ago that I was annoyed that he hadn't lodged for OSA months ago! I understand that they are a little stretched and all focus was on getting FDA over the line but IMO more multitasking needs to be achieved because those double blind OSA results that we are sitting on are nothing short of bloody awesome! I even stated to him that I believe OSA could bring in more revenue especially in the short term over the cough diagnostics, however he disagreed and thinks the cough diagnostics will bring in more revenue (BL thinks like me) I couldn't argue after that because he obviously knows more in relation to what's coming for the coughing diagnostic technology but lodge already, yeah! He reinforced that lodgment will take place before the month is out. He is still unsure whether the data that was published here from the Australian study will suffice the FDA he will find out very soon as they may require a study conducted on their home soil because they need our foreign money, let's face it that's what it's really about. In my opinion I don't think the submission would be de Novo more like 510K submission which is more achievable.. if a separate study needs to be conducted in the United States I would be against moving this into the US market for the time being until we achieve sustainable revenue from European and Australian sales whether that be from the coughing diagnostic side of things and or the Sleep Apnea side things once cleared... just bring in some revenue already we all deserve to see dollars flowing through the company by now... . We have a unique situation presented in front of us at the moment, close sales, leverage the opportunity reinforce a sustainable future for this company that is self revenue generated and not funded by the likes of shareholders propping up the bank balance.. I know you can do it team, rise up you have world-class technology close a sale, create shareholder value and help the world during this epidemic..

Go RAP!

Cheers

Red bar

Expand

Hi Red bar,

Yes I agree the OSA data was awesome. Did you inquire as to price per use to public as Tony stated this will be sold direct to consumer via app stores.

Some time ago Tony stated in a conference call $100.00 per use.
I am wondering if this is still what RAP management are thinking of charging for per use of OSA sleep study app.

I believe it needs to be a serious price for a serious study.
If it is going to be $100.00 per use globally then I agree the income has the potential to be awesome.

Forget USA!
They have had our cake and burnt it twice.
Move on
Move on
Move on

MB

RAP Price at posting: 8.7¢ Sentiment: Buy Disclosure: Held
12 Upvote

0 Great analysis

Reply

Top Stories

IMU

Imugene kicks off Australian trial for blood cancer treatment

FG1

Flynn Gold reaches milestone exploration target for Golden Ridge

Week 45 Wrap: Combat sports usher in Trump 2.0 – or is it male insecurity?; RBA boring; Propane suggests China alive

HotCopper Highlights: Your most watched and most discussed stocks this week

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Trump is President Again: What Does This Mean for Crypto?

UBI

Universal Biosensors flat despite fresh deal with US medical product distributor

MMI

Metro Mining inks bauxite offtake contracts into 2026 with Chinese m

Palladium's the newest geopolitical hot commodity. But ASX exposure is limited

Trump Victory Sends Bitcoin Surging Above $75K – Is $100K Next?